Holding(s) in Company

Byotrol PLC
08 April 2024
 

Logo, company name Description automatically generated

 

 




Byotrol Plc

("Byotrol" or the "Company")

 

Holdings in Company

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that it has received notification that as of 5 April 2024, Mr & Mrs D Newlands no longer have a notifiable interest in the Company's issued share capital.

 

 

For further information contact:

 

Byotrol Plc


Dr Trevor Francis, Non- Executive Chairman

+44 (0)1925 742 000

David Traynor, Interim Chief Executive Officer

Chris Sedwell, Chief Financial Officer

 




Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Geoff Nash/George Dollemore - Corporate Finance

Nigel Birks/Harriet Ward - ECM






Flagstaff Strategic and Investor Communications

+44 (0)20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon                                          

 

byotrol@flagstaffcomms.com

 

 

 

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the animal and human healthare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings